IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Return on Assets [ROA] (2019 - 2026)

Updated

IRulya Therapeutics (IRLA) reported Return on Assets [ROA] of -122.83% for Q2 2026, down 79.11 percentage points from -43.72% a year earlier and down 67.83 percentage points from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, IRulya Therapeutics posted Return on Assets [ROA] of -80.75%, down 40.50 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of -31.77 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -40.25% in FY2024 (-17.16 pp), -23.09% in FY2023 (+20.48 pp) and -43.57% in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] in data going back to Q1 2019.
  • Year over year, Return on Assets [ROA] has now declined in each of the last nine quarters, with an average year-over-year change of -24.87 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q3 2022 (a gain of 74.35 percentage points); the low point was Q2 2026 (a drop of 79.11 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -54.99% (Q1 2026), -82.57% (Q4 2025) and -50.18% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 8.08%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 7.32%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 1.87%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 9.36%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 9.80%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -7.67%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 2.00%
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -122.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -122.83%
Mar 31, 2026 -54.99%
Dec 31, 2025 -82.57%
Sep 30, 2025 -50.18%
Jun 30, 2025 -43.72%
Mar 31, 2025 -54.80%
Dec 31, 2024 -47.16%
Sep 30, 2024 -40.76%
Jun 30, 2024 -36.12%
Mar 31, 2024 -18.51%
Dec 31, 2023 -24.78%
Sep 30, 2023 -32.17%
Jun 30, 2023 -33.59%
Mar 31, 2023 -42.87%
Dec 31, 2022 -48.35%
Sep 30, 2022 17.94%
Jun 30, 2022 5.67%
Mar 31, 2022 1.16%
Sep 30, 2021 -56.41%
Jun 30, 2021 -51.74%
API Access

IRulya Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IRLA&period=max&api_key=YOUR_API_KEY